THE production of very high voltage X-rays for therapy is now a practical possibility, limited mainly by the expense of installing the equipment and running it.
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It is a long way from the drawing board to the construction and installation of practical equipment responding to the controls. It is also a long time before series of cases can be collected of sufficient number on a stabilized technique for analysis. It takes a further period of years before the survival results of cancer cases treated on these techniques can be of statistical significance. In Sheffield we have had the use of a two million volt X-ray generator for three years only, and it is still very early to talk about survival results.
ADVANTAGES OF HIGH VOLTAGE IRRADIATION
Going up the energy scale from orthodox 200/250 kilovolts for deep X-ray therapy, there is a very gradual alteration in the physical characteristics requiring a very considerable rise in energy to effect comparatively small changes in penetration. So much is this the case that it is not until the million or two million volt level is reached that any considerable gain is achieved. Two million volt X-ray really does begin to make a difference, and provides something economically possible and practical in between the present orthodox X-ray equipment and the betatrons and synchrotrons or linear accelerators in the ten to fifty million volt range. It is also similar to what we would get out of a high output cobaltiunit.
I)M VAN DE GRAAF GENERATOR
The Van de Graaf Generator was the most economic answer at the time we ordered our machine in 1946, and two million volts was the practical economic limit to such a machine being mobile. So we decided on the 2 MeV level, the radiation of which is intermediate between conventional deep X-ray therapy and the ultra-high voltage.
Physical factors which interest us particularly are:
(1) Quality of radiation.
(2) Build up } Together dependent upon (1). (3) Penetration j (4) Isodose distribution for different fields.
At the same time the practical possibilities of making use of these factors clinically depend upon mechanical and electrical qualities of the machine to an extent soon apparent to anyone dependent upon one single unit. To wit:
(1) Reliability.
(2) Output.
(3) Manceuvrability and ease of control.
(4) Ease of servicing and replacement of parts.
(5) Accuracy of beam definition. There are other factors, such as economy of operation, which should not be lost sight of.
CLINIcAL AssEssMENTr
The value and advantages of 2 MeV radiation must ultimately be based upon practical experience, and a great many things come into the picture. Survival statistics, for which considerable time is required, with comparable control series, are regarded by many as the acid test of efficacy. Other things for which we may not have to wait so long can be assessed sooner. Treatment without "high dose effects"-generally referred to by our medical and surgical colleagues as "radiation burns" or "radionecrosis"-is of great importance, and the general relief or control of disease without severe cutaneous reactions or nauseating radiation sickness is a great benefit. The avoidance of tedious treatment, with long sessions under the X-ray and multiple fields, which many ill patients cannot stand, is also a great boon to the patient and a great convenience.
EXPECTED GAINS Returning to expected gains from physical factors, let us consider skin and mucosal reactions. The clinical effect is about what could be expected, assuming that the basal-cell zone of the skin is the most important structure in the mechanism of skin reactions. Skin reactions are not wholly predictable with orthodox radiation, and one finds that certain sites are far more susceptible than others. Irritating discharges have aggravating effects, and trophic skin changes will make the skin sensiive to any injury, physical or otherwise. To give typical examples of reactions to the 2 MeV radiation which are visible-a skin dose of 4,000 r over the pelvis, made up of 3,000 r incident and 1,000 r from the opposite side, fractionated to five doses per week for four weeks, will give a mild erythema only, with a more marked reaction over the pubes. This is with 15 x 15 cm. fields to cover, a substantial area; smaller fields will give less reaction. Where, however, the radiation glances and touches the skin tangentially, or where there is a fold taking the skin into the depth of the tissues, there will be more marked reaction; in fact the skin reaction is then what one would expect with full "build up" and approaches the reaction obtained at the same dose with conventional deep X-ray.
As a fairly good test of the build-up effect, we have observed and compared reactions on the incident and exit sides, using a single field on the limb or neck. In treatment of the larynx by a single field 6 x 8 cm., the skin reaction at the opposite side of the neck is roughly the same as over the incident side. An exit dose of 3,000 r, given in four weeks, results in a slight to moderate erythema similar to that caused by an incident dose of 5,000 r. The gain in depth dose is greatest for small fields and for considerable depth. This is due to greater penetration and forward scatter. Side scatter is less and the tumour area can be covered with greater accuracy than with conventional methods provided the aim is accurate. Table I shows build-up and penetration for small and medium-sized fields. 200 kV. X-ray is shown in adjoining columns for comparison. Fig. 1 shows two comparable fields, at 2 MeV and at 200 kV. Mucosal reactions at depth give us a fair assessment of the biological effect. Mouth, pharynx and larynx cases have been carefully observed by all of us at Sheffield, and the actual clinical reaction of the mucosa in mouth, pharynx and larynx differs but slightly from reactions obtained with radiation at 200 kV., and comes on at a slightly higher dose level. There is of course no "build up" here unless the patient is given a direct beam through the open mouth. We have found that 6,000 r units given to the mucosa, such as in the treatment of carcinoma of the larynx, in an overall time of five weeks, gives rise to reactions very similar to what we find at 5,000 r units in the same overall time at 200 kV.
BEAM DEFINITION
As judged by the clinical reactions, the cut-off, using tungsten blocks at 35 cm. and a 70 cm. Focal Skin Distance, is quite as accurate as it is with orthodox radiation. For such special work as treating the posterior hemisphere of the eye by a lateral field, special inserts can be used which enable smaller fields to be accurately defined.
As regards Focal Skin Distance, isodose distribution charts show that 70 cm. F.S.D. is ideal for routine work. For large cross sections and for extreme thicknesses between opposed surfaces, 100 cm. F.S.D. may be necessary. For rotational therapy an increased distance will be necessary for clearance purposes, and for very large fields the usual long distances are of no detriment as treatment times will still be short. CLINICAL RESULTS In planning our programme of clinical work the order of things has been:
(1) Physical investigations for six months, during which the general performance of the machine was tuned up. (2) A period of six months or so on a combined programme of physical and clinical work. The clinical programme commenced in December 1949, and for the purpose of reviewing the work I have taken all the 19S0 cases. These have been followed up on an average for a period of just over two years. This will not give very much statistical weight on survival times, but it has left me with very definite impressions on how the patients fared.
One general impression of some significance is that patients are not frightened by these machines.
(1)
FIG. I.-Two X-ray isodose charts for single field, 6 cm. wide x 8 cm.: (1) 200 kV. 40 cm. F.S.D.;
(2) 2 MeV 70 cm. F.S.D.
So long as they are properly handled by the staff they have immense confidence and they very much prefer a machine which is not touching the person, i.e. without applicators pressing upon them. The total number of cases treated in the two-year period (December 1949 to December 1951) was 749. Table II gives the classification of the chief series included. Intracranial tumours.-There are obvious advantages in using supervoltage X-ray therapy as opposed to conventional deep X-ray for intracranial tumours, and almost all our cases were referred from the Neurosurgical Department, mostly after an incomplete removal. Of 20 cases treated in 1950 and 2 Ptroceding of the Royal Scity of Medicine 4 cases ofchromophobe adenoma of the pituitary gland, 9 were alive up to October 1952. These included 3 cases of meningioma, 2 cases of ependymoma, one case of h . angioblastoma and one case of medulloblastoma. An isodose chart for a multiple field treatment is shown, Fig. 2 . A beam direction technique is illustrated in Fig. 3 Mouth cases.-The mouth cases treated were mostly diffibult ones unsuitable for radium or ordinary techniques, such as carcinoma involving the mandible and with secondary glands of the neck. Good survival results could not be expected on this account, but some individual cases did well. An example is illustrated, before and after treatment ( Figs. 4 and 5) .
Carcinoma of larynx and pharynx.-A single field would serve well for an intrinsic growth without secondary glands, but we have generally found it advisable to be more radical and use two opposed fields. These can be wedged by lead filters to give a uniform through and through dose. As we are now using the cobalt beam for early cases the tendency has been to reserve supervoltage for the more' extensive ones where considerable advantage is likely to be gained. Carcinoma ofesophagus.-Of 9 cases treated in 1950 one survived for nearly two years and died from secondary extensions. Palliation was good in all cases well enough to receive a full course of treatment.
Malignant tumours of the bladder.-There are very great advantages to be obtained by using supervoltage X-ray therapy as opposed to conventional deep X-ray for treatment of inoperable tumours of the bladder. The two isodose charts shown in Fig. 6 will give evidence ofthis. Accurate localization is necessary and this is done both from the front and from the back by tube shift, the two halves (2) 2 MeV 70 cm. F.S.D.
being plotted separately and joined together with the tumour level correct for each. Of a total of 26 cases treated in 1950, 11 are alive and well and the living include some cases of extensive growth treated by stipervoltage X-ray therapy alone. Carcinoma ofbronchus.-We have not attempted to treat many lung cases. Of 14 treated in 1950 one carcinoma of bronchus is alive (24.10.52) with a recurrence.
Carcinoma ofrectum.-14 cases were treated in 1950 with inoperable growths of the rectum. Good palliation was obtained. 10 died within one year and one has died since. 2 are alive with persistent growth two years after treatment.
Artificial menopause.-This non-malignant series was included as a matter of policy and also to test for the gamma ray dose necessary to produce artificial menopause by external irradiation. The treatment has usually been given as a single dose of 350 to 450 r to the mid-pelvis, by two opposed fields 15 x 15 cm. The bigger dose is given to the younger patients. The single treatment has proved almost 100 % effective so far and appears to be sufficient. For obese patients with a deep pelvis it has been better policy to fractionate a larger dose, and anything above 400 r through the pelvis in a single treatment is liable to cause an undesirable intestinal reaction in a proportion of cases. This reaction clears up quickly but can be severe whilst it lasts.
Carcinoma ofuterine cervix.-This series is one of importance and interest. The policy has been to treat all cases of carcinoma of the uterine cervix with supplementary supervoltage X-ray therapy in addition to the radium treatment, and some stage 3 and stage 4 cases were treated by external irradiation alone. Of 112 cases treated in 1950, 55 % were alive up to October 31, 1952. The supplementary radiation was given to raise the dose to Point B' up to 3,500 r total in the early cases and up to-4,000 r or 4,500 r or even to 5,000 r in the more advanced cases where there was clinical evideiice of spread to the parametrium or to pelvic glands. The method by which this is now done is by two opposed fields suitably blocked in the middle, using a lead filter graded off at the parallel edges. This filter was omitted when radium was unsuitable in the very advanced cases. When in use it is attached by two magnets and adjusted by the optical field-defining device (Fig. 7) .
We have found this a very simple and convdnient way of giving the radiation, and in the course of time we should have a statistically significant series to compare with the previous years when conventional deep X-ray therapy was used. We have not had any appreciable complications and have been significantly free from such grave complications as recto-vaginal and vesico-vaginal fistula. We have found it desirable to take the dose up at the rate of 800 to 1,000 r per week to the pelvic wall.
Miscellaneous cases.-A number of miscellaneous cases, such as breast tumours presenting special problems, ovarian tumours and soft tissue sarcomas, have been treated. It has not been possible to include breast tumours as routine cases owing to their number and the time which would be necessary, but it is well worth including such cases if apparatus is available.
Conclusion.-The experience of the past three years, during which time we have used the 2 MeV machine, leavesgme in no doubt that the chagge to supervoltage X-ray therapy for the treatment of deep-seated cancer, and indeed certain other cancers and lesions, is as well justified as the change from 150 kV. to 200 kV. X-radiation which took place about twenty years ago. There is, as ever, the necessity for accurate localization and direction of treatment, but the ease with which the treatment can be administered and the almost complete elimination of severe skin reactions, combined with the gain in accurate delivery of the radiation where it is required, is an immense advantage.
Mr. G. R. Newbery asked the speaker to comment on the possible value of supervoltage X-ray therapy and to inform the meeting of the techniques he has used or intends to use, in the treatment of carcinoma of the breast.
Dr. N. S. Finzi said that at St. Bartholomew's Hospital a slight but quite definite improvement in results was found when the voltage was raised to a million and this occurred not only in deep growths, but also in relatively superficial growths such as maxillary antrum, thus indicating a change in the biological value of the shorter wave-length X-rays. The preliminary results described in this discussion seemed to indicate that this improvement was carried further with the increased voltage. He noted that the very poor output of the synchrotron limits greatly the number of cases that can be treated. St. Bartholomew's had on order a linear accelerator to work at 15 million volts. Shouldn't this give a considerably higher output than the synchrotron? Dr. G. Spiegler remarked on a similarity between the dose distribution obtained from the synchrotron and that achieved with 200 kV. by the technique of convergence therapy, in which the tube focus describes a spiral movement on the surface of a spherical cap, a method used by Nielsen (Copenhagen) and by Wachsmann and Barth (Erlangen).
Mr. G. W. Blomfield, in reply to Mr. Newbery, said that breast cases could not be included as routine but a limited number of breast cases were treated and very considerable advantage was obtained over orthodox techniques by virtue of the better depth-dose delivered to the axillary and supraclavicular glands. He used beam-directed glancing fields for the breast and treated the axillary and supraclavicular glands by two opposed fields, delivering a depth dose of 5,000 r units in four weekls.
lThe Point B referred to is defined as 5 cm. lateral to the mid-line of the uterus and 2 cm. above the vaginal vault. It is near the pelvic wall.
